Chemical stock jumps over 4% from today's low following stock market rebound. Do you own?
Sudarshan Pharma shares surged nearly 4% to ₹20.25 after reporting Q3FY26 revenue of ₹158.37 crore, a 37% YoY increase. Net profit rose 56% to ₹43.05 crore. Despite a 27.40% drop in January, the stock shows a strong long-term gain of 165%.
Sudarshan Pharma shares surged nearly 4% to ₹20.25 after reporting Q3FY26 revenue of ₹158.37 crore, a 37% YoY increase. Net profit rose 56% to ₹43.05 crore. Despite a 27.40% drop in January, the stock shows a strong long-term gain of 165%.
What's Your Reaction?
Economist Admin
Admin managing news updates, RSS feed curation, and PR content publishing. Focused on timely, accurate, and impactful information delivery.
